MBX
MBX Biosciences, Inc.
57.72
+1.39 (+2.47%)
52w low 23.07
72.64 high
69.9% of range
Financial Analysis
| (USD) | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -17.43M | -21.54M | -18.30M | -20.21M | -22.62M | |
| Depreciation & Amort | 61.00K | 50.00K | 60.00K | 64.00K | 79.00K | |
| Capital Expenditure | -707.00K | -399.00K | -793.00K | -437.00K | -901.00K | |
| Free Cash Flow | -18.14M | -21.93M | -19.09M | -20.64M | -23.52M | |
| Investing Cash Flow | 25.99M | 17.06M | -129.97M | -97.10M | 29.21M | |
| Financing Cash Flow | 1.33M | 187.82M | 438.00K | 87.44M | 2.32M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--